U.S. CENTRAL VENOUS CATHETER MARKET ANALYSIS

U.S. Central Venous Catheter Market, by Product Type (Peripherally Inserted Central Catheters (PICC), Implantable Ports, Tunneled Central Venous Catheter, and Non-tunneled Central Venous Catheter), by Design (Single Lumen, Double Lumen, and Multi Lumen), by Composition (Polyurethane, Polyethylene, and Silicon), by Procedure (Cardiovascular Procedure, Chemotherapy Procedure, and Dialysis Procedure), and by End User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics)- Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031

Published In : Mar 2024
Code : CMI2610
Pages :117
Formats :
Excel and PDF
Industry : Medical Devices

Market News

Recent Developments

In November 2023, CorMedix Inc., a biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has approved DefenCath (taurolidine and heparin) catheter lock solution (CLS) to reduce the incidence of catheter-related bloodstream infections (CRBSIs) in a limited population of adult kidney failure patients receiving chronic hemodialysis via a central venous catheter (CVC).

In June 2023, Merit Medical Systems, Inc., a global medical device manufacturer, announced that it has completed the purchase of Bluegrass Vascular Technologies, Inc. Surfacer Inside-Out Access Catheter System for a total cash consideration of USD 32.5 million. The Surfacer System is a life-saving device for hemodialysis patients on catheters, as well as patients with other illnesses requiring venous access, who experience central venous occlusions.

In August 2022, Teleflex Incorporated, a leading global provider of medical technologies, announced that it has been granted a contract by Vizient, Inc., the largest member-driven healthcare performance improvement firm in the U.S., to deliver Central Venous Access products. Vizient Inc. offers solutions and services that improve the delivery of high-value care by harmonizing cost, quality, and market performance for more than half of the country\'s acute care providers.